These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines. Wegmann A, Glück R, Just M, Mischler R, Paroz P, Germanier R. Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778 [Abstract] [Full Text] [Related]
27. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes. Coté TR, Sivertson D, Horan JM, Lindegren ML, Dwyer DM. Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775 [Abstract] [Full Text] [Related]
32. Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Weibel RE, Carlson AJ, Villarejos VM, Buynak EB, McLean AA, Hilleman MR. Proc Soc Exp Biol Med; 1980 Nov; 165(2):323-6. PubMed ID: 7443721 [No Abstract] [Full Text] [Related]
33. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M. Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [Abstract] [Full Text] [Related]
37. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related]
38. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. Just M, Berger R, Glück R, Wegmann A. Dev Biol Stand; 1986 Nov 24; 65():25-7. PubMed ID: 3549399 [Abstract] [Full Text] [Related]